Skip to main content
. 2021 Jan 21;32(3):695–706. doi: 10.1681/ASN.2020081181

Table 3.

Chronicity findings in LMN on rebiopsy

Case Glomeruli/Sclerosed IFTA, % Follow-Up, yr Rebiopsy: Glomeruli/Sclerosed Rebiopsy: IFTA, %
1 17/1 (5.9%) 0 2 17/2 (11.8%) 0
2 10/0 (0%) 0 2 26/0 (0%) 0
3 3/0 (0%) 0 10 42/2 (4.8%) 0
4 7/0 (0%) 0 7 42/19 (45.2%) 25

Cases 1–3 are EXT1/EXT2-positive LMN and case 4 is EXT1/EXT2-negative LMN.